Boan Biosimilar Prolia Wins Bolivia Approval, Targets Global Markets
CompanyDrug

Boan Biosimilar Prolia Wins Bolivia Approval, Targets Global Markets

Johnson & Johnson Strikes Tariff Exemption Deal with Trump Administration
Others

Johnson & Johnson Strikes Tariff Exemption Deal with Trump Administration

Hybio Pharmaceutical Licenses Semaglutide to Vitamedic for Brazil Market
CompanyDeals

Hybio Pharmaceutical Licenses Semaglutide to Vitamedic for Brazil Market

CompanyDeals

Merck in Talks to Acquire Revolution Medicines for $28‑32 Billion in Oncology Push

Genrix Bio's GR1803 NDA Accepted for BCMA-Targeted Multiple Myeloma Therapy
CompanyDrug

Genrix Bio’s GR1803 NDA Accepted for BCMA-Targeted Multiple Myeloma Therapy

CompanyDrug

RemeGen’s RC48 Wins Fourth Breakthrough Therapy Designation for Gastric Cancer Combo

CompanyDrug

Merck Initiates Phase 3 Trial for Calderasib + KEYTRUDA QLEX in KRAS G12C NSCLC

CompanyDeals

Takeda Licenses Halozyme’s ENHANZE Technology for Vedolizumab in Global Deal

CompanyDrug

Hansoh Pharmaceutical’s Ameile Wins Fifth NMPA Indication for EGFR‑Mutated NSCLC

CompanyDeals

Eisai China and Xuanwu Hospital Forge Strategic Cooperation for Drug R&D

CompanyDrug

Imunopharm’s IM19 CAR‑T Wins NMPA IND for Second‑Line NHL Therapy

CompanyDeals

InduPro Partners with Lilly on $950M Oncology Deal Using Proximity-Guided Platform